Home » Topics » Regulatory

Regulatory
RSS

FDA first to approve GlaxoSmithKline's Nucala

Nov. 5, 2015

FDA approves Imlygic as first oncolytic viral therapy in U.S.

Oct. 28, 2015

FDA approves Belbuca buccal film for chronic pain

Oct. 28, 2015

FDA approves Yondelis for liposarcoma and leiomyosarcoma

Oct. 26, 2015

FDA approves Merrimack's liposomal irinotecan for pancreatic cancer

Oct. 23, 2015

FDA approves Veltassa for hyperkalemia

Oct. 22, 2015

FDA approves Coagadex for hereditary factor X deficiency

Oct. 21, 2015

FDA approves Praxbind as dabigatran reversal agent

Oct. 19, 2015

FDA approves Aristada for schizophrenia

Oct. 6, 2015

Maruho's Zebiax approved in Japan for bacterial skin infections

Sep. 30, 2015